features: Molecular Profiling

VJOncology is excited to present the latest data and developments in the HER2-low breast cancer field, with comments from experts…

As of the 23rd March 2022, the U.S. Food and Drug Administration (FDA) has approved 177Lu-PSMA-617 (a.k.a. Lu 177 Vipivotide…

Highlights from ASCO 2021 in lung cancer! Learn more about the major clinical trials reported at this year’s meeting.

VJOncology presents highlights from this year’sEuropean Association of Urology (EAU) Virtual Meeting 2021!

VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

VJOncology presents highlights from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

The Food and Drug Administration (FDA) granted accelerated approval to dostarlimab on April 2021 for patients with recurrent or advanced…

VJOncology presents highlights from this year’s virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress!